Fundraising Fox
Claire Brown
InvestorPartner at Oxford Science Enterprises
Oxford, United Kingdom
Writes $100K – $5M checks · typically $1.5M
Find your path to Claire
Sign up to see every warm intro you have to Claire
- Paths you didn't know you had: your email and LinkedIn already hold routes to Claire. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Claire Brown has over 20 years of biopharmaceutical experience across the UK and US, spanning R&D strategy, licensing, business development and corporate investment. At OSE she leads company creation and portfolio strategy in Life Sciences, having joined in 2020 after roles at UCB, Sanofi-Genzyme, AstraZeneca and as Head of Investment at Pioneer Group.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Investor
AlveogeneRinri TherapeuticsScripta Therapeutics
Per curated public sources.
Colleagues at Oxford Science Enterprises
Network5
Investors connected to Claire in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Claire Brown?
- Claire Brown has over 20 years of biopharmaceutical experience across the UK and US, spanning R&D strategy, licensing, business development and corporate investment. At OSE she leads company creation and portfolio strategy in Life Sciences, having joined in 2020 after roles at UCB, Sanofi-Genzyme, AstraZeneca and as Head of Investment at Pioneer Group.
- Where does Claire Brown work?
- Claire Brown is Partner at Oxford Science Enterprises.
- What does Claire Brown invest in?
- Claire Brown invests in Biotech.
- What check size does Claire Brown write?
- Claire Brown typically writes checks of $100K – $5M.
- What companies has Claire Brown invested in?
- Investments tracked here include Alveogene, Rinri Therapeutics, Scripta Therapeutics.
About this profile. Compiled from public sources — Oxford Science Enterprises's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights